(1)
E. Kerboua1, Z.Benlahrech2, R.Benyahia3. Sorafenib in Iodo-Refractory Thyroid Cancer : Experience of Medical Oncology Department of Pierre and Marie Curie Center Algiers Algeria. ijmscrr 2024, 7, Page: 494-496.